Skip to content

Clinical trials

Neoplasm Metastasis trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: Taiwan Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20051
20064
20073
20086
20096
20103
20112
20128
20135
20149
20158
20169
20176
201811
20199
20207
202118
202212
20234
202410
202513
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Active, not recruiting30
Recruiting28
Terminated26
Unknown status16
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca21
Eli Lilly and Company13
Novartis Pharmaceuticals10
National Taiwan University Hospital9
Chang Gung Memorial Hospital7
Pfizer7
Daiichi Sankyo5
AbbVie4
Amgen3
Clovis Oncology, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis162
Neoplasms35
Carcinoma, Non-Small-Cell Lung34
Breast Neoplasms33
Recurrence19
Colorectal Neoplasms12
Lung Neoplasms12
Stomach Neoplasms11
Carcinoma10
Pancreatic Neoplasms9

Trials

Showing 76 to 100 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.